Medication info
Tenelams Extended-Release Tablet 10/500 mg

Tenelams Extended-Release Tablet 10/500 mg

Prescription medicationTabletOral
Ingredient · strength
Teneligliptin Hydrochloride Hydrate›13mg / 1 tabletMetformin Hydrochloride›500mg / 1 tablet
Manufacturer / importer
Medica Korea Co., Ltd.
Appearance
Orange oblong extended-release film-coated tablet
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 202201311 · Approved 2022.04.04 · Insurance code 646005510

Summary

Main use
Improvement of glycemic control in patients with type 2 diabetes mellitus
Who takes it
Adults
Adult dose
The dose of this medicine should be determined based on each patient's current treatment regimen, efficacy, and tolerability. This medicine is generally administered once daily with the evening meal, and the dose should be titrated gradually to reduce gastrointestinal adverse reactions associated with metformin. Take one 20/1000mg extended-release tablet once daily. Patients taking the 10/750mg or 10/500mg extended-release tablets should take 2 tablets together once daily. In patients whose blood glucose is not adequately controlled with metformin monotherapy, the initial dose of this medicine should provide teneligliptin 20 mg once daily and the patient's current dose of metformin. In patients switching from combination therapy with teneligliptin and metformin to this medicine, treatment may be initiated at the patient's current doses of teneligliptin and metformin. When switching from immediate-release metformin to an extended-release formulation, blood glucose control should be closely monitored, and the dose should be adjusted as appropriate. When co-administered with a sulfonylurea, a reduction in the sulfonylurea dose may be considered to reduce the risk of hypoglycemia. The maximum recommended daily dose is teneligliptin 20mg and extended-release metformin 2000mg. The safety and efficacy of this medicine have not been specifically evaluated in patients switching to it from other glucose-lowering agents. Because such a change may lead to changes in blood glucose control, any changes in the treatment of patients with type 2 diabetes mellitus should be made under careful monitoring. To maintain its extended-release properties, this medicine should be swallowed whole and not split, crushed, ground, or chewed.

Ingredients

Manufacturer
Medica Korea Co., Ltd.

Efficacy & effects

Improvement of glycemic control in patients with type 2 diabetes mellitus

View approved original text

This medication is used in conjunction with diet and exercise to help control blood sugar in patients with type 2 diabetes. The combined action of teneligliptin and metformin effectively lowers blood sugar levels, improving blood sugar management for patients. This treatment method stabilizes blood sugar levels and facilitates better diabetes management. Therefore, this medication is used to improve blood sugar control in patients with type 2 diabetes.

How to take

Adult dose

The dose of this medicine should be determined based on each patient's current treatment regimen, efficacy, and tolerability. This medicine is generally administered once daily with the evening meal, and the dose should be titrated gradually to reduce gastrointestinal adverse reactions associated with metformin. Take one 20/1000mg extended-release tablet once daily. Patients taking the 10/750mg or 10/500mg extended-release tablets should take 2 tablets together once daily. In patients whose blood glucose is not adequately controlled with metformin monotherapy, the initial dose of this medicine should provide teneligliptin 20 mg once daily and the patient's current dose of metformin. In patients switching from combination therapy with teneligliptin and metformin to this medicine, treatment may be initiated at the patient's current doses of teneligliptin and metformin. When switching from immediate-release metformin to an extended-release formulation, blood glucose control should be closely monitored, and the dose should be adjusted as appropriate. When co-administered with a sulfonylurea, a reduction in the sulfonylurea dose may be considered to reduce the risk of hypoglycemia. The maximum recommended daily dose is teneligliptin 20mg and extended-release metformin 2000mg. The safety and efficacy of this medicine have not been specifically evaluated in patients switching to it from other glucose-lowering agents. Because such a change may lead to changes in blood glucose control, any changes in the treatment of patients with type 2 diabetes mellitus should be made under careful monitoring. To maintain its extended-release properties, this medicine should be swallowed whole and not split, crushed, ground, or chewed.

Precautions

This medication can very rarely cause a serious condition known as lactic acidosis. Lactic acidosis is a dangerous condition caused by excessive accumulation of lactic acid in the body, which can be life-threatening without appropriate treatment. When taking this medication with other diabetes medications, particularly when combined with insulin or sulfonylureas, there is a risk of severe hypoglycemia, so caution should be exercised. Patients with moderate to severe renal impairment or weakened cardiac function, or those in serious conditions such as acute myocardial infarction or sepsis, should not use this medication. Patients scheduled for tests using iodine contrast agents should stop taking this medication 48 hours before the test, and only resume taking it after renal function has been confirmed as normal following the test. Women who are pregnant or may become pregnant are advised not to use this medication, and it is also not recommended for breastfeeding mothers. During treatment, patients should be aware of the symptoms of hypoglycemia and take appropriate measures, such as immediately consuming food containing sugar if symptoms occur. Patients with impaired liver function, severe pulmonary disease, or excessive alcohol consumption should also avoid using this medication. If abnormal symptoms such as abdominal pain, vomiting, severe constipation, difficulty breathing, fever, rash, etc. occur during use, consultation with healthcare professionals should be sought immediately. Elderly patients may experience decreased renal function, so regular renal function tests should be performed, and the medication dose may need to be adjusted accordingly. This medication can lower vitamin B12 levels in some patients, so it is important to check vitamin levels through regular blood tests. Additionally, it is safe to avoid alcohol consumption while taking this medication. Patients facing surgery should temporarily discontinue this medication 48 hours prior to the procedure, and resume taking it after renal function has been confirmed as normal post-surgery. Patients taking this medication are at risk of hypoglycemia, so extra caution should be taken when driving or performing dangerous tasks at heights. Lastly, there may be other medications that can interact with this medication, so it is essential to inform healthcare providers about any other medications being taken.

Side effects

  • Severe lactic acidosis
  • severe hypoglycemia
  • hypoglycemia
  • constipation
  • intestinal obstruction
  • liver dysfunction
  • interstitial pneumonia
  • pemphigus vulgaris
  • acute pancreatitis
  • dizziness
Show 140 more
  • abdominal distension
  • abdominal discomfort
  • nausea
  • abdominal pain
  • bloating
  • stomatitis
  • gastric polyps
  • colonic polyps
  • duodenal ulcer
  • gastroesophageal reflux disease
  • diarrhea
  • loss of appetite
  • elevated amylase
  • elevated lipase
  • elevated AST (GOT)
  • elevated ALT (GPT)
  • elevated GGT
  • elevated ALP
  • proteinuria
  • ketonuria
  • potential hematuria
  • eczema
  • rash
  • itching
  • allergic dermatitis
  • arthralgia
  • elevated CK (CPK)
  • increased serum potassium concentration
  • fatigue
  • allergic rhinitis
  • elevated serum uric acid
  • peripheral edema
  • herpes zoster
  • limb pain
  • epigastric pain
  • gastritis
  • upper respiratory infection
  • tremor
  • headache
  • weakness
  • hunger
  • fatigue
  • facial edema
  • dyspepsia
  • nausea
  • viral upper respiratory infection
  • rhinitis
  • sweating
  • diabetic retinopathy
  • vision deterioration
  • cough
  • pulmonary congestion
  • dyspnea
  • drug overdose
  • benign prostatic hyperplasia
  • headache
  • dizziness
  • cerebral infarction
  • paresthesia
  • diabetic neuropathy
  • tension-type headache
  • peripheral neuropathy
  • facial paralysis
  • sciatica
  • orthostatic dizziness
  • muscle weakness
  • low back pain
  • lumbar spinal canal stenosis
  • tendinitis
  • cervical pain
  • bone pain
  • osteoarthritis
  • osteoporosis
  • muscle cramps
  • foot deformity
  • hypertrophic osteoarthritis
  • bursitis
  • spinal osteoarthritis
  • spinal intervertebral disc protrusion
  • spinal intervertebral disc disorder
  • spinal ligament ossification
  • spinal foraminal stenosis
  • postmenopausal osteoporosis
  • rotator cuff syndrome
  • gastroenteritis
  • vomiting
  • chronic gastritis
  • stomatitis
  • gastrointestinal motility disorder
  • gastrointestinal motility slowdown
  • enteritis
  • dental pain
  • anal rectal discomfort
  • acquired mixed hyperlipidemia
  • hypertriglyceridemia
  • vitamin D deficiency
  • abnormal weight gain
  • essential hypertension
  • orthostatic hypotension
  • white coat hypertension
  • iliac artery stenosis
  • bleeding
  • increased blood sugar
  • abnormal sputum
  • elevated blood creatinine
  • increased blood urea
  • anemia
  • food allergy
  • pressure sore ulcer
  • cataract
  • glaucoma
  • blurred vision
  • age-related macular degeneration
  • hyperthyroidism
  • hyperparathyroidism
  • coronary artery disease
  • unstable angina
  • angina
  • otalgia
  • vertigo
  • iron deficiency anemia
  • urticaria
  • depression
  • insomnia
  • ovarian cyst
  • vulvar pruritus
  • menopausal symptoms
  • bile duct obstruction
  • toxic hepatitis
  • chronic cholecystitis
  • non-alcoholic fatty liver disease
  • alcoholic liver disease
  • eyelid damage
  • ligament sprain
  • lip injury
  • contusion
  • foot fracture
  • diarrhea
  • nausea
  • vomiting

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent exposure to air, and it is recommended to be kept at room temperature between 1 to 30 degrees Celsius. Storing it this way helps maintain the medication's effectiveness and prevents deterioration.

Appearance and packaging

Appearance

Orange oblong extended-release film-coated tablet

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.